fuberidazole has been researched along with tamoxifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, HI; Ali, MM; El Diwani, HI; Ragab, FA; Shaker, YM; Temirak, A | 1 |
| Abdel-Mohsen, HT; Abdullaziz, MA; Abu-Bakr, SM; Ali, MM; El Diwani, HI; El Kerdawy, AM; Girgis, AS; Ragab, FAF | 1 |
2 other study(ies) available for fuberidazole and tamoxifen
| Article | Year |
|---|---|
Part I. Synthesis, biological evaluation and docking studies of new 2-furylbenzimidazoles as antiangiogenic agents.
Topics: Angiogenesis Inhibitors; Benzimidazoles; Drug Evaluation, Preclinical; Humans; Mass Spectrometry; MCF-7 Cells; Molecular Docking Simulation; Proton Magnetic Resonance Spectroscopy; Structure-Activity Relationship | 2014 |
Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Topics: Antineoplastic Agents; Benzimidazoles; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Furans; Hep G2 Cells; Humans; MCF-7 Cells; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2 | 2017 |